Literature DB >> 28186390

Pain management in the Ehlers-Danlos syndromes.

Pradeep Chopra, Brad Tinkle, Claude Hamonet, Isabelle Brock, Anne Gompel, Antonio Bulbena, Clair Francomano.   

Abstract

Chronic pain in the Ehlers-Danlos syndromes (EDS) is common and may be severe. According to one study, nearly 90% of patients report some form of chronic pain. Pain, which is often one of the first symptoms to occur, may be widespread or localized to one region such as an arm or a leg. Studies on treatment modalities are few and insufficient to guide management. The following is a discussion of the evidence regarding the underlying mechanisms of pain in EDS. The causes of pain in this condition are multifactorial and include joint subluxations and dislocations, previous surgery, muscle weakness, proprioceptive disorders, and vertebral instability. Affected persons may also present with generalized body pain, fatigue, headaches, gastrointestinal pain, temporomandibular joint pain, dysmenorrhea, and vulvodynia. Pain management strategies may be focused around treating the cause of the pain (e.g., dislocation of a joint, proprioceptive disorder) and minimizing the sensation of pain. Management strategies for chronic pain in EDS includes physical therapy, medications, as well as durable medical equipment such as cushions, compressive garments, and braces. The different modalities are discussed in this paper.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ehlers-Danlos syndrome; hypermobility; joint pain; neuropathic; pain; pelvic pain; proprioception

Mesh:

Year:  2017        PMID: 28186390     DOI: 10.1002/ajmg.c.31554

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  27 in total

1.  Systemic manifestations of Ehlers-Danlos syndrome.

Authors:  Bo Song; Peter Yeh; John Harrell
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-26

Review 2.  Urogenital and pelvic complications in the Ehlers-Danlos syndromes and associated hypermobility spectrum disorders: A scoping review.

Authors:  Elizabeth Gilliam; Jodi D Hoffman; Gloria Yeh
Journal:  Clin Genet       Date:  2019-09-01       Impact factor: 4.438

Review 3.  [Syndromes with skin fragility].

Authors:  A Reimer; C Has
Journal:  Hautarzt       Date:  2019-07       Impact factor: 0.751

Review 4.  The challenges of chronic pain and fatigue.

Authors:  Jessica A Eccles; Kevin A Davies
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

5.  Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.

Authors:  Weiyi Mu; Michael Muriello; Julia L Clemens; You Wang; Christy H Smith; Phuong T Tran; Peter C Rowe; Clair A Francomano; Antonie D Kline; Joann Bodurtha
Journal:  Am J Med Genet A       Date:  2019-01-31       Impact factor: 2.802

Review 6.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

Review 7.  Clinical Relevance of Joint Hypermobility and Its Impact on Musculoskeletal Pain and Bone Mass.

Authors:  Vito Guarnieri; Marco Castori
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

Review 8.  Left to themselves: Time to target chronic pain in childhood rare diseases.

Authors:  Christine B Sieberg; Alyssa Lebel; Erin Silliman; Scott Holmes; David Borsook; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2021-03-24       Impact factor: 8.989

Review 9.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

10.  Pain Management through Neurocognitive Therapeutic Exercises in Hypermobile Ehlers-Danlos Syndrome Patients with Chronic Low Back Pain.

Authors:  Claudia Celletti; Teresa Paolucci; Loredana Maggi; Giordana Volpi; Mariangela Billi; Roberta Mollica; Filippo Camerota
Journal:  Biomed Res Int       Date:  2021-06-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.